Serina Therapeutics
SER
Serina Therapeutics (SER) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$0.66
- EPS estimate
- −$0.43
- EPS surprise
- −55.29%
- Revenue surprise
- +0.00%
- Revenue
- $130,000.00
- Revenue estimate
- $0.00
- Reported
- Aug 11, 2025
Earnings history
Quarterly revenue
Frequently asked questions
When did Serina Therapeutics (SER) last report earnings?
Serina Therapeutics last reported on Aug 11, 2025, covering fiscal Q2 2025.
Did SER beat earnings estimates?
No. Serina Therapeutics reported EPS of −$0.66 for Q2 2025 against a −$0.43 estimate — a 55.29% miss.
How much revenue did SER report last quarter?
Serina Therapeutics reported $130,000.00 in revenue for Q2 2025.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.